Functional Dyspepsia
An Enigma in a Conundrum
Corresponding Author
Claudio Romano
Pediatric Department, University of Messina, Messina, Italy
Address correspondence and reprint requests to Claudio Romano, MD, Department of Pediatrics, University of Messina, Via Consolare Valeria, 1-98124 Messina ME, Italy (e-mail: [email protected]).Search for more papers by this authorSimona Valenti
Pediatric Department, University of Messina, Messina, Italy
Search for more papers by this authorSabrina Cardile
Pediatric Department, University of Messina, Messina, Italy
Search for more papers by this authorMarc A. Benninga
Department of Pediatric Gastroenterology and Nutrition, Emma Children's Hospital/Academic Medical Centre, Amsterdam, The Netherlands
Search for more papers by this authorCorresponding Author
Claudio Romano
Pediatric Department, University of Messina, Messina, Italy
Address correspondence and reprint requests to Claudio Romano, MD, Department of Pediatrics, University of Messina, Via Consolare Valeria, 1-98124 Messina ME, Italy (e-mail: [email protected]).Search for more papers by this authorSimona Valenti
Pediatric Department, University of Messina, Messina, Italy
Search for more papers by this authorSabrina Cardile
Pediatric Department, University of Messina, Messina, Italy
Search for more papers by this authorMarc A. Benninga
Department of Pediatric Gastroenterology and Nutrition, Emma Children's Hospital/Academic Medical Centre, Amsterdam, The Netherlands
Search for more papers by this authorThe authors report no conflicts of interest.
ABSTRACT
As defined by Rome III, there are 4 abdominal pain-related functional gastrointestinal disorders in children: irritable bowel syndrome, functional dyspepsia (FD), abdominal migraine, and functional abdominal pain. Dyspepsia is a constellation of symptoms referable to the gastroduodenal region of the upper gastrointestinal tract. FD refers to dyspeptic symptoms that cannot currently be explained by an organic cause, and affects 25% to 40% of the adult population over a lifetime. In children, this condition results in increased specialist consultations, with reported prevalence between 3% and 27%. The Rome III criteria for pediatric FD include the presence or persistence of recurrent pain or discomfort centered in the upper abdomen, without evidence of organic disease or change in frequency of stools. Symptoms must be chronic, occurring at least weekly and over a period of at least 6 months. The goal of this article is to provide a narrative review of diagnosis and management of the FD in the pediatric population. A comprehensive search of published literature using the PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) database was carried out to identify all articles published in English from 1998 to November 2015, using 3 key terms; “FD,” “functional gastrointestinal disorders,” and “children.”
REFERENCES
- 1.Tack J, Talley NJ. Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria. Nat Rev Gastroenterol Hepatol 2013; 10: 134–141.
- 2.Ganesh M, Nurko S. Functional dyspepsia in children. Pediatr Ann 2014; 43: e101–e105.
- 3.Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466–1479.
- 4.Talley NJ, Ford AC. Functional dyspepsia. N Engl J Med 2015; 373: 1853–1863.
- 5.Van Zanten S, Flook N, Chiba N. An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. CMAJ 2000; 162 (suppl 12): S3–S23.
- 6.Quigley EM, Lacy BE. Overlap of functional dyspepsia and GERD-diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol 2013; 10: 175–186.
- 7.Turco R, Russo M, Martinelli M, et al. Do distinct functional dyspepsia subtypes exist in children? J Pediatr Gastroenterol Nutr 2016; 62: 387–392.
- 8.Pleyer C, Bittner H, Lock GR III, et al. Overdiagnosis of gastroesophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community. Neurogastroenterol Motil 2014; 26: 1163–1171.
- 9.Feinle-Bisset C, Vozzo R, Horowitz M, et al. Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004; 99: 170–181.
- 10.Tack J, Piessevaux H, Coulie B, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346–1352.
- 11.Sha W, Pasricha PJ, Chen JD. Correlations among electrogastrogram, gastric dysmotility, and duodenal dysmotility in patients with functional dyspepsia. J Clin Gastroenterol 2009; 43: 716–722.
- 12.Perri F, Clemente R, Festa V, et al. Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying. Am J Gastroenterol 1998; 93: 2082–2088.
- 13.Haag S, Senf W, Tagay S, et al. Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia? Neurogastroenterol Motil 2010; 22: 262–279.
- 14.Overland MK. Dyspepsia. Med Clin North Am 2014; 98: 549–564.
- 15.Devanarayana NM, Rajindrajith S, Perera M, et al. Gastric emptying and antral motility parameters in children with functional dyspepsia: association with symptom severity. J Gastroenterol Hepatol 2013; 28: 1161–1166.
- 16.Talley NJ, Locke GR III, Lahr BD, et al. Functional dyspepsia, delayed gastric emptying and impaired quality of life. Gut 2006; 55: 933–939.
- 17.Tack J, Talley NJ. Gastroduodenal disorders. Am J Gastroenterol 2010; 105: 757–763.
- 18.Oustamanolakis P, Tack J. Dyspepsia: organic versus functional. J Clin Gastroenterol 2012; 46: 175–190.
- 19.Li X, Cao Y, Wong RK, et al. Visceral and somatic sensory function in functional dyspepsia. Neurogastroenterol Motil 2013; 25: 246–253.
- 20.Shurman V, Singh M, Singh V, et al. Symptoms and subtypes in pediatric functional dyspepsia: relation to mucosal inflammation and psychological functioning. J Pediatr Gastroenterol Nutr 2010; 51: 298–303.
- 21.Caldarella MP, Azpiroz F, Malagelada JR. Antro-fundic dysfunctions in functional dyspepsia. Gastroenterology 2003; 124: 1220–1229.
- 22.Samsom M, Verhagen MA, Van Berge, et al. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999; 116: 515–520.
- 23.Piessevaux H, De Winter B, Louis E, et al. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil 2009; 21: 378–388.
- 24.Fugarami S, Itoh T, Sakamoto C. Systematic review with meta-analysis: post-infectious functional dyspepsia. Aliment Pharmacol Ther 2015; 41: 177–188.
- 25.Mearin F, Perez-Oliveras M, Perello A, et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow up cohort study. Gastroenterology 2005; 129: 98–104.
- 26.Kindt S, Tertychnyy A, De Hertogh G, et al. Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil 2009; 21: 832–856.
- 27.Rosen JM, Cocjin JT, Schurman JV, et al. Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia. World J Gastrointest Pharmacol Ther 2014; 5: 122–138.
- 28.Haug TT, Wilhelmsen I, Berstad A. Life events and stress in patients with functional dyspepsia compared with patients with duodenal ulcer and healthy controls. Scand J Gastroenterol 1995; 30: 524–530.
- 29.Schurman JV, Danda CE, Friesen CA, et al. Variations in psychological profile among children with recurrent abdominal pain. J Clin Psychol Med Settings 2008; 15: 241–251.
- 30.Hou XH, Zhu LR, Li QX, et al. Alterations in mast cells and 5-HT positive cells in gastric mucosa in functional dyspepsia patients with hypersensitivity. Neurogastroenterol Motil 2001; 13: 398–399.
- 31.Toyoshima F, Oshima T, Nakajima S, et al. Serotonin transporter gene polymorphism may be associated with functional dyspepsia in a Japanese population. BMC Med Genet 2011; 12: 88.
- 32.Oshima T, Nakajima S, Yokoyama T, et al. The G-protein beta3 subunit 825 TT genotype is associated with epigastric pain syndrome-like dyspepsia. BMC Med Genet 2010; 11: 3.
- 33.Talley NJ, Ruff K, Jiang X, et al. The Rome III classification of dyspepsia: will it help research? Dig Dis 2008; 26: 203–209.
- 34.Xiao YL, Peng S, Tao J, et al. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria. Am J Gastroenterol 2010; 105: 2626–2631.
- 35.Ford AC, Marwaha A, Lim A, et al. Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol 2010; 8: 401–409.
- 36.Delgado-Aros S, Locke GR, Camilleri M, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol 2004; 99: 1801–1806.
- 37.Jones MP, Talley NJ, Eslick GD, et al. Community subgroups in dyspepsia and their association with weight loss. Am J Gastroenterol 2008; 103: 2051–2060.
- 38.Aro P, Talley NJ, Ronkainen J, et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology 2009; 137: 94–100.
- 39.Rippel SW, Acra S, Correa H, et al. Pediatric patients with dyspepsia have chronic symptoms, anxiety, and lower quality of life as adolescents and adults. Gastroenterology 2012; 142: 754–761.
- 40.Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006; CD002096.
- 41.Suzuki H, Moayyedi P. Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 168–174.
- 42.Den Hollander WJ, Sostres C, Kuipers EJ, et al. Helicobacter pylori and nonmalignant diseases. Helicobacter 2013; 18 (suppl 1): 24–27.
- 43.Mazzoleni LE, Sander GB, Francesconi CF, et al. Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Arch Intern Med 2011; 171: 1929–1936.
- 44.Hoffman I, Vos R, Tack J. Assessment of gastric sensorimotor function in paediatric patients with unexplained dyspeptic symptoms and poor weight gain. Neurogastroenterol Motil 2007; 19: 173–179.
- 45.Mullan A, Kavanagh P, O’Mahony P, et al. Food and nutrient intakes and eating patterns in functional and organic dyspepsia. Eur J Clin Nutr 1994; 48: 97–105.
- 46.Park R, Mikami S, LeClair J, et al. Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009. Neurogastroenterol Motil 2015; 27: 684–692.
- 47.Gijsbers CF, Benninga MA, Schweizer JJ, et al. Validation of the Rome III criteria and alarm symptoms for recurrent abdominal pain in children. J Pediatr Gastroenterol Nutr 2014; 58: 779–785.
- 48.Brun R, Kuo B. Functional dyspepsia. Therap Adv Gastroenterol 2010; 3: 145–164.
- 49.Benninga MA, Mayer EA. The power of placebo in pediatric functional gastrointestinal disease. Gastroenterology 2009; 137: 1207–1210.
- 50.Moayyedi P, Talley NJ, Fennerty MB, et al. Can the clinical history distinguish between organic and functional dyspepsia? JAMA 2006; 295: 1566–1576.
- 51.Feinle-Bisset C, Azpiroz F. Dietary and lifestyle factors in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 150–157.
- 52.Teitelbaum JE, Sinha P, Micale M, et al. Obesity is related to multiple functional abdominal diseases. J Pediatr 2009; 154: 444–446.
- 53.Moayyedi P, Delaney BC, Vakil N, et al. The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004; 127: 1329–1337.
- 54.See MC, Birnbaum AH, Schechter CB, et al. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment. Dig Dis Sci 2001; 46: 985–992.
- 55.Dehghani SM, Imanieh MH, Oboodi R, et al. The comparative study of the effectiveness of cimetidine, ranitidine, famotidine, and omeprazole in treatment of children with dyspepsia. ISRN Pediatr 2011; 2011: 219287.
- 56.Riezzo G, Cucchiara S, Chiloiro M, et al. Gastric emptying and myoelectrical activity in children with nonulcer dyspepsia. Effect of cisapride. Dig Dis Sci 1995; 40: 1428–1434.
- 57.Kusunoki H, Haruma K, Manabe N, et al. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography. Neurogastroenterol Motil 2012; 24: 540–545.
- 58.Matsueda K, Hongo M, Tack J, et al. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut 2012; 61: 821–828.
- 59.Miranda A, Saps M. The use of non-narcotic pain medication in pediatric gastroenterology. Paediatr Drugs 2014; 16: 293–307.
- 60.Diaz J, Nurko S. Safety and efficacy of cyproheptadine for treating dyspeptic symptoms in children. J Pediatr 2013; 163: 261–267.
- 61.Passos Mdo C, Duro D, Fregni F. CNS or classic drugs for the treatment of pain in functional dyspepsia? A systematic review and meta-analysis of the literature. Pain Physician 2008; 11: 597–609.
- 62.Teitelbaum JE, Arora R. Long-term efficacy of low-dose tricyclic antidepressant for children with functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr 2011; 53: 260–264.
- 63.Xu S, Zha H, Hou X, et al. Electroacupuncture accelerates solid gastric emptying in patients with functional dyspepsia. Gastroenterology 2004; 126: A–437.
- 64.Sebastián-Domingo JJ. Integrative medicine in the management of functional dyspepsia. Role of the herbal preparation STW5. Gastroenterol Hepatol 2014; 37: 256–261.
- 65.Bortolotti M, Coccia G, Grossi G, et al. The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther 2002; 16: 1075–1082.
- 66.Mozaffari S, Rahimi R, Abdollahi M. Implications of melatonin therapy in irritable bowel syndrome: a systematic review. Curr Pharm Des 2010; 16: 3646–3655.
- 67.Zybach K, Friesen CA, Schurman JV. Therapeutic effect of melatonin on pediatric functional dyspepsia: a pilot study. World J Gastrointest Pharmacol Ther 2016; 7: 56–161.
10.4292/wjgpt.v7.i1.156 Google Scholar
- 68.Klupińska G, Poplawski T, Drzewoski J, et al. Therapeutic effect of melatonin in patients with functional dyspepsia. J Clin Gastroenterol 2007; 41: 270–274.
- 69.Pasalar M, Choopani R, Mosaddegh M, et al. Efficacy and safety of jollab to treat functional dyspepsia: a randomized placebo-controlled clinical trial. Explore (NY) 2015; 11: 199–207.
- 70.Romano C, Chiaro A, Comito D, et al. Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy. Curr Clin Pharmacol 2011; 6: 41–47.